Olaf Stuve is a Neurology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd
Dallas, TX 753907208
Telephone
214-645-0624Registry record last updated 8 Jul 2007.
Clinical trials
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
Sponsor: Dallas VA Medical Center
- Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
Sponsor: University of Texas Southwestern Medical Center
- Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Merck KGaAProgram year20241 payment
- Genentech, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Defining the role of CD11c+CD88+CD317+ myeloid cells as mediators of CNS autoimmunity
Va North Texas Health Care System
FY2026I01BX005664 - Immune Checkpoint-Engineered oligodendrocytes as treatment for multiple sclerosis
Ut Southwestern Medical Center
FY2025$300,000R56AI188482 - Defining the role of CD11c+CD88+CD317+ myeloid cells as mediators of CNS autoimmunity
Va North Texas Health Care System
FY2025I01BX005664
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”